A vaccinia-based elispot assay for detection of CD8+ T cells from HIV-1 infected children

Journal of Immunological Methods

Volumn 298, Issue 1-2, 2005, Pages 105-118

  Buseyne, Florence ^a   Catteau, Adeline ^a   Scott Algara, Daniel ^b   Corre, Béatrice ^a   Porrot, Françoise ^a   Rouzioux, Christine ^c   Blanche, Stéphane ^d   Rivière, Yves ^a  

^a CNRS   (France)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Cytotoxic T lymphocytes (CTL); Elispot; Perinatal HIV infection

Indexed keywords

ANTIGEN; ANTIRETROVIRUS AGENT; GAG PROTEIN; GAMMA INTERFERON; POL PROTEIN; VIRUS ENVELOPE PROTEIN;

ACCURACY; ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; CHILD; CHROMIUM 51 RELEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS RECOMBINANT;

HUMAN IMMUNODEFICIENCY VIRUS 1; VACCINIA; VACCINIA VIRUS;

EID: 17444370900     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2005.01.003     Document Type: Article

References (60)

1. J. Andersson, H. Behbahani, J. Lieberman, E. Connick, A. Landay, B. Patterson, A. Sonnerborg, K. Lore, S. Uccini, and T.E. Fehniger Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection AIDS 13 1999 1295
2. V. Appay, and S.L. Rowland-Jones Premature ageing of the immune system: the cause of AIDS? Trends Immunol. 23 2002 580
3. V. Appay, D.F. Nixon, S.M. Donahoe, G.M.A. Gillespie, T. Dong, A. King, G.S. Ogg, H.M.L. Spiegel, C. Conlon, C.A. Spina, D.V. Havlir, D.D. Richman, A. Waters, P. Easterbrook, A.J. McMichael, and S.L. Rowland-Jones HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function J. Exp. Med. 192 2000 63
4. C. Brander, and B.D. Walker Gradual adaptation of HIV to human host populations: good or bad news? Nat. Med. 9 2003 1359
5. F. Buseyne, S. Blanche, D. Schmitt, C. Griscelli, and Y. Rivière Detection of HIV-specific cell-mediated cytotoxicity in the peripheral blood from infected children J. Immunol. 150 1993 3569
6. F. Buseyne, M. Burgard, J.P. Teglas, E. Bui, C. Rouzioux, M.J. Mayaux, S. Blanche, and Y. Rivière Early human immunodeficiency virus (HIV)-specific cytotoxic T lymphocytes (CTL) and disease progression in children born to HIV-infected mothers AIDS Res. Hum. Retrovir. 14 1998 1435
7. F. Buseyne, M.L. Chaix, B. Fleury, O. Manigard, M. Burgard, S. Blanche, C. Rouzioux, and Y. Riviere Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children Virology 250 1998 316
8. F. Buseyne, M.L. Chaix, C. Rouzioux, S. Blanche, and Y. Riviere Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children J. Virol. 75 2001 4941
9. F. Buseyne, J. Le Chenadec, B. Corre, F. Porrot, M. Burgard, C. Rouzioux, S. Blanche, M.J. Mayaux, and Y. Riviere Inverse correlation between memory gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children J. Infect. Dis. 186 2002 1589
10. F. Buseyne, D. Scott-Algara, F. Porrot, B. Corre, N. Bellal, M. Burgard, C. Rouzioux, S. Blanche, and Y. Rivière Frequencies of ex vivo-activated human immunodeficiency virus type 1-specific gamma-interferon-producing CD8+ T cells in infected children correlate positively with plasma viral load J. Virol. 76 2002 12414
11. P. Champagne, G.S. Ogg, A.S. King, C. Knabenhans, K. Ellefsen, M. Nobile, V. Appay, G.P. Rizzardi, S. Fleury, M. Lipp, R. Forster, S. Rowland-Jones, R.P. Sekaly, A.J. McMichael, and G. Pantaleo Skewed maturation of memory HIV-specific CD8 T lymphocytes Nature 410 2001 106
12. J. Choppin, W. Cohen, A. Bianco, J.P. Briand, F. Connan, M. Dalod, and J.G. Guillet Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation J. Immunol. 166 2001 6164
13. C. Chouquet, B. Autran, E. Gomard, J.M. Bouley, V. Calvez, C. Katlama, D. Costagliola, Y. Rivière, and I.S. Grp Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection AIDS 16 2002 2399
14. J.R. Currier, E.G. Kuta, E. Turk, L.B. Earhart, L. Loomis-Price, S. Janetzki, G. Ferrari, D.L. Birx, and J.H. Cox A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays J. Immunol. Methods 260 2002 157
15. M. Dalod, M. Harzic, I. Pellegrin, B. Dumon, B. Hoen, D. Sereni, J.C. Deschemin, J.P. Levy, A. Venet, and E. Gomard Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy J. Infect. Dis. 178 1998 61
16. S.G. Deeks Treatment of antiretroviral-drug-resistant HIV-1 infection Lancet 362 2003 2002
17. D.C. Douek, L.J. Picker, and R.A. Koup T cell dynamics in HIV-1 infection Annu. Rev. Immunol. 21 2003 265
18. P.J.R. Goulder, Y.H. Tang, C. Brander, M.R. Betts, M. Altfeld, K. Annamalai, A. Trocha, S.Q. He, E.S. Rosenberg, G. Ogg, C.A. O'Callaghan, S.A. Kalams, R.E. McKinney, K. Mayer, R.A. Koup, S.I. Pelton, S.K. Burchett, K. McIntosh, and B.D. Walker Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children J. Exp. Med. 192 2000 1819
19. V. Haridas, T.W. McCloskey, R. Pahwa, and S. Pahwa Discordant expression of perforin and granzyme A in total and HIV-specific CD8 T lymphocytes of HIV infected children and adolescents AIDS 17 2003 2313
20. T. Heintel, M. Sester, M.M.B. Rodriguez, C. Krieg, U. Sester, R. Wagner, H.W. Pees, B. Gartner, R. Maier, and A. Meyerhans The fraction of perforin-expressing HIV-specific CD8 T cells is a marker for disease progression in HIV infection AIDS 16 2002 1497
21. X.L. Huang, Z. Fan, C. Kalinyak, J.W. Mellors, and C.R. Rinaldo CD8+ T-cell gamma interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjects Clin. Diagn. Lab. Immunol. 7 2000 279
22. A.C. Karlsson, J.N. Martin, S.R. Younger, B.M. Bredt, L. Epling, R. Ronquillo, A. Varma, S.G. Deeks, J.M. McCune, D.F. Nixon, and E. Sinclair Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells J. Immunol. Methods 283 2003 141
23. A. Lalvani, R. Brookes, S. Hambleton, W.J. Britton, A.V. Hill, and A.J. McMichael Rapid effector function in CD8+ memory T cells J. Exp. Med. 186 1997 859
24. M. Larsson, X. Jin, B. Ramratnam, G.S. Ogg, J. Engelmayer, M.A. Demoitie, A.J. McMichael, W.I. Cox, R.M. Steinman, D. Nixon, and N. Bhardwaj A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals AIDS 13 1999 767
25. M. Lichterfeld, X.G. Yu, M.T. Waring, S.K. Mui, M.N. Johnston, D. Cohen, M.M. Addo, J. Zaunders, G. Alter, E. Pae, D. Strick, T.M. Allen, E.S. Rosenberg, B.D. Walker, and M. Altfeld HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8+ T cells producing both interferon-gamma and tumor necrosis factor-alpha Blood 104 2004 487
26. M. Lucchiari-Hartz, V. Lindo, N. Hitziger, S. Gaedicke, L. Saveanu, P.M. van Endert, F. Greer, K. Eichmann, and G. Niedermann Differential proteasomal processing of hydrophobic and hydrophilic protein regions: contribution to cytotoxic T lymphocyte epitope clustering in HIV-1-Nef Proc. Natl. Acad. Sci. U. S. A. 100 2003 7755
27. K. Luzuriaga, R.A. Koup, C.A. Pikora, D.B. Brettler, and J.L. Sullivan Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children J. Pediatr. 119 1991 230
28. K. Luzuriaga, D. Holmes, A. Hereema, J. Wong, D.L. Panicali, and J.L. Sullivan HIV-1-specific cytotoxic T lymphocyte responses in the first year of life J. Immunol. 154 1995 433
29. K. Luzuriaga, M. McManus, M. Catalina, S. Mayack, M. Sharkey, M. Stevenson, and J.L. Sullivan Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses J. Virol. 74 2000 6984
30. M. McChesney, F. Tanneau, A. Regnault, P. Sansonetti, L. Montagnier, M.P. Kieny, and Y. Rivière Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env amino-terminal signal sequence Eur. J. Immunol. 20 1990 215
31. E.J. McFarland, P.A. Harding, D. Luckey, B. Conway, R.K. Young, and D.R. Kuritzkes High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection J. Infect. Dis. 170 1994 766
32. S.A. Migueles, A.C. Laborico, W.L. Shupert, M.S. Sabbaghian, R. Rabin, C.W. Hallahan, D. Van Baarle, S. Kostense, F. Miedema, M. McLaughlin, L. Ehler, J. Metcalf, S.Y. Liu, and M. Connors HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors Nat. Immunol. 3 2002 1061
33. P. Moingeon, J. Almond, and M. de Wilde Therapeutic vaccines against infectious diseases Curr. Opin. Microbiol. 6 2003 462
34. K. Murali-Krishna, J.D. Altman, M. Suresh, D.J.D. Sourdive, A.J. Zajac, J.D. Miller, J. Slansky, and R. Ahmed Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection Immunity 8 1998 177
35. M. Mwau, A.J. McMichael, and T. Hanke Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines AIDS Res. Hum. Retrovir. 18 2002 611
36. E. Papasavvas, J.K. Sandberg, R. Rutstein, E.C. Moore, A. Mackiewicz, B. Thiel, M. Pistilli, R.R. June, K.A. Jordan, R. Gross, V.C. Maino, D.F. Nixon, and L.J. Montaner Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression J. Infect. Dis. 188 2003 873
37. J.L. Petersen, C.R. Morris, and J.C. Solheim Virus evasion of MHC class I molecule presentation J. Immunol. 171 2003 4473
38. C.A. Power, C.L. Grand, N. Ismail, N.C. Peters, D.P. Yurkowski, and P.A. Bretscher A valid ELISPOT assay for enumeration of ex vivo, antigen-specific, IFNgamma-producing T cells J. Immunol. Methods 227 1999 99
39. Y. Rivière, and F. Buseyne Cytotoxic T lymphocytes generation capacity in early life with particular reference to HIV Vaccine 16 1998 1420
40. Y. Rivière, M.B. McChesney, F. Porrot, F. Tanneau-Salvadori, P. Sansonetti, O. Lopez, G. Pialoux, V. Feuillie, M. Mollereau, S. Chamaret, F. Tekaia, and L. Montagnier Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS AIDS Res. Hum. Retrovir. 11 1995 903
41. N.D. Russell, M.G. Hudgens, R. Ha, C. Havenar-Daughton, and J. McElrath Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity J. Infect. Dis. 187 2003 226
42. F. Sallusto, D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 401 1999 708
43. J.K. Sandberg, N.M. Fast, K.A. Jordan, S.N. Furlan, J.D. Barbour, G. Fennelly, J. Dobroszycki, H.M.L. Spiegel, A. Wiznia, M.G. Rosenberg, and D.F. Nixon HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment J. Immunol. 170 2003 4403
44. C. Scheibenbogen, K.H. Lee, S. Mayer, S. Stevanovic, U. Moebius, W. Herr, H.G. Rammensee, and U. Keilholz A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients Clin. Cancer Res. 3 1997 221
45. C. Scheibenbogen, P. Romero, L. Rivoltini, W. Herr, A. Schmittel, J.C. Cerottini, T. Woelfel, A.M.M. Eggermont, and U. Keilholz Quantitation of antigen-reactive T cells in peripheral blood by IFN gamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial J. Immunol. Methods 244 2000 81
46. A. Schmittel, U. Keilholz, S. Bauer, U. Kuhne, S. Stevanovic, E. Thiel, and C. Scheibenbogen Application of the IFN-gamma ELISPOT assay to quantify T cell responses against proteins J. Immunol. Methods 247 2001 17
47. Z.A. Scott, E.G. Chadwick, L.L. Gibson, M.D. Catalina, M.M. McManus, R. Yogev, P. Palumbo, J.L. Sullivan, P. Britto, H. Gay, and K. Luzuriaga Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8+ T cell responses in young HIV-1-infected infants J. Immunol. 167 2001 7134
48. D. Scott-Algara, F. Buseyne, S. Blanche, C. Rouzioux, C. Jouanne, F. Romagné, and Y. Rivière Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramers J. Infect. Dis. 183 2001 1565
49. U. Seifert, C. Maranon, A. Shmueli, J.F. Desoutter, L. Wesoloski, K. Janek, P. Henklein, S. Diescher, M. Andrieu, H. de la Salle, T. Weinschenk, H. Schild, D. Laderach, A. Galy, G. Haas, P.M. Kloetzel, Y. Reiss, and A. Hosmalin An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope Nat. Immunol. 4 2003 375
50. P. Shankar, M. Russo, B. Harnisch, M. Patterson, P. Skolnik, and J. Lieberman Impaired function of circulating HIV-specific CD8+ T cells in chronic human immunodeficiency virus infection Blood 96 2000 3094
51. J.G. Smith, X. Liu, R.M. Kaufhold, J. Clair, and M.J. Caulfield Development and validation of a gamma interferon Elispot assay for quantitation of cellular immune responses to Varicella-Zoster virus Clin. Diagn. Lab. Immunol. 8 2001 871
52. H.M. Spiegel, R. Chandwani, M.E. Sheehy, J. Dobroszycki, G. Fennelly, A. Wiznia, J. Radding, M. Rigaud, H. Pollack, W. Borkowsky, M. Rosenberg, and D.F. Nixon The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in children J. Infect. Dis. 182 2000 88
53. M. Subklewe, A. Chahroudi, K. Bickham, M. Larsson, M.G. Kurilla, N. Bhardwaj, and R.M. Steinman Presentation of Epstein-Barr virus latency antigens to CD8+, interferon-gamma-secreting T lymphocytes Eur. J. Immunol. 29 1999 3995
54. Y. Sun, E. Iglesias, A. Samri, G. Kamkamidze, T. Decoville, G. Carcelain, and B. Autran A systematic comparison of methods to measure HIV-1 specific CD8 T cells J. Immunol. Methods 272 2003 23
55. L.C. Tan, N. Gudgeon, N.E. Annels, P. Hansasuta, C.A. O'Callaghan, S. Rowland-Jones, A.J. McMichael, A.B. Rickinson, and M.F. Callan A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers J. Immunol. 162 1999 1827
56. F. Tanneau, M. McChesney, O. Lopez, P. Sansonetti, L. Montagnier, and Y. Riviere Primary cytotoxicity against the envelope glycoprotein of human immunodeficiency virus-1: evidence for antibody-dependent cellular cytotoxicity in vivo J. Infect. Dis. 162 1990 837
57. L.A. Trimble, and J. Lieberman Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3 zeta, the signaling chain of the T-cell receptor complex Blood 91 1998 585
58. L.A. Trimble, P. Shankar, M. Patterson, J.P. Daily, and J. Lieberman Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3 zeta and CD28, key signaling molecules for T-cell activation J. Virol. 74 2000 7320
59. E.J. Wherry, and R. Ahmed Memory CD8 T-cell differentiation during viral infection J. Virol. 78 2004 5535
60. J.Q. Xu, F. Lori, and J. Lisziewicz Vaccinia assay for the rapid detection of functional HIV-specific CD8+ cytotoxic T lymphocytes J. Immunol. Methods 276 2003 45